Common pain pills may hold key to stopping hereditary cancer
NCT ID NCT05411718
Summary
This study is testing whether two common over-the-counter pain relievers, aspirin or naproxen, can help prevent cancer in people with Lynch syndrome, a genetic condition that greatly increases cancer risk. Researchers will give 40 participants one of the drugs for a year and use colon biopsies to see if the medications boost helpful immune cells in the colon lining. The goal is to see if these safe, existing drugs can be repurposed as a preventive treatment for this high-risk group.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for COLORECTAL CANCER are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
MD Anderson Cancer Center
RECRUITINGHouston, Texas, 77030, United States
Contact
Contact
Conditions
Explore the condition pages connected to this study.